pro and cons of semaglutide vs Tirzepatide πΏ The Truth About Semaglutide
Description
When you draw to the 40-unit mark, you are drawing 0.4mL of liquid
As such, it is difficult to know why some doctors have lower ratings than others
That trial supports a 2024 FDA label expansion making semaglutide indicated for cardiovascular risk reduction in adults with overweight or obesity and prior CV disease
The FDA continues to monitor these medications through routine pharmacovigilance
